You are here

Article info

Article menu

Download PDFPDF

Review
Genomic approaches to cancer and minimal residual disease detection using circulating tumor DNA

Authors

  • Nicholas P Semenkovich Division of Endocrinology, Metabolism, and Lipid Research, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA PubMed articlesGoogle scholar articles
  • Jeffrey J Szymanski Division of Cancer Biology, Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri, USA PubMed articlesGoogle scholar articles
  • Noah Earland Division of Biology and Biomedical Sciences, Washington University School of Medicine, St. Louis, Missouri, USA PubMed articlesGoogle scholar articles
  • Pradeep S Chauhan Division of Cancer Biology, Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri, USA PubMed articlesGoogle scholar articles
  • Bruna Pellini Department of Thoracic Oncology, Moffitt Cancer Center and Research Institute, Tampa, Florida, USADepartment of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA PubMed articlesGoogle scholar articles
  • Aadel A Chaudhuri Division of Cancer Biology, Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri, USADivision of Biology and Biomedical Sciences, Washington University School of Medicine, St. Louis, Missouri, USASiteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri, USADepartment of Genetics, Washington University School of Medicine, St. Louis, Missouri, USADepartment of Biomedical Engineering, Washington University School of Medicine, St. Louis, Missouri, USADepartment of Computer Science and Engineering, Washington University in St. Louis, St. Louis, Missouri, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Aadel A Chaudhuri; aadel{at}wustl.edu
View Full Text

Citation

Semenkovich NP, Szymanski JJ, Earland N, et al
Genomic approaches to cancer and minimal residual disease detection using circulating tumor DNA
Journal for ImmunoTherapy of Cancer 2023;11:e006284. doi: 10.1136/jitc-2022-006284

Publication history

  • Accepted May 26, 2023
  • First published June 22, 2023.
Online issue publication 
June 22, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.